Targeting bacteria causing otitis media using nanosystems containing nonspherical gold nanoparticles and ceragenins

Author:

Prasad Suhanya V1,Piktel Ewelina1ORCID,Depciuch Joanna2ORCID,Maximenko Alexey3,Suprewicz Łukasz1,Daniluk Tamara1,Spałek Jakub45,Wnorowska Urszula1,M Zielinski Piotr2,Parlinska-Wojtan Magdalena2,B Savage Paul6,Okła Sławomir5,Fiedoruk Krzysztof1,Bucki Robert1ORCID

Affiliation:

1. Department of Medical Microbiology & Nanobiomedical Engineering, Medical University of Bialystok, PL-15222, Bialystok, Poland

2. Institute of Nuclear Physics Polish Academy of Sciences, PL-31342, Krakow, Poland

3. SOLARIS National Synchrotron Radiation Centre, Jagiellonian University, PL-30392, Krakow, Poland

4. Department of Pathology, Collegium Medicum, Jan Kochanowski University in Kielce, PL-25317, Kielce, Poland

5. Department of Otolaryngology, Head & Neck Surgery, Holy Cross Cancer Center in Kielce, PL-25734, Kielce, Poland

6. Department of Chemistry & Biochemistry, Brigham Young University, Provo, UT 84604, USA

Abstract

Aim: To evaluate the antibacterial and antibiofilm activity of ceragenin-conjugated nonspherical gold nanoparticles against the most common agents of otitis media. Methods: Minimal inhibitory and bactericidal concentrations and colony-counting assays, as well as colorimetric and fluorimetric methods, were used to estimate the antibacterial activity of compounds in phosphate-buffered saline and human cerumen. The nanosystems’ biocompatibility and ability to decrease IL-8 release was tested using keratinocyte cells. Results: The tested compounds demonstrated strong antimicrobial activity against planktonic and biofilm cultures at nontoxic doses due to the induction of oxidative stress followed by the damage of bacterial membranes. Conclusion: This study indicates that ceragenin-conjugated nonspherical gold nanoparticles have potential as new treatment methods for eradicating biofilm-forming pathogens associated with otitis media.

Funder

Narodowe Centrum Nauki

European Union's Horizon 2020

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3